Form 4 for PHR Phreesia, Inc.
Accepted 2024-09-19 00:00:00 ET · period of report 2024-09-17 · accession 0001127602-24-024260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-19 | 2024-09-17+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.34 | -97 | 8,995 | -1% | -$2,361 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-17 | S | D | 36 | $24.77 | 9,056 | I By Spouse | — | — | |
| 2 | Common | Common Stock | 2024-09-18 | S | D | 61 | $24.09 | 8,995 | I By Spouse | — | — |